Healthy Japanese subjects
Conditions
Interventions
Test food: (1) Test food A (2) Test food B Administration: <
Test food A>
After taking blood samples before intake, take test food A (270 mg) with water (100 mL) <
Test food B>
After taking blood samples before intake, take test food B (300 mg) with water (100 mL) *The intervention sequence is test food A to test food B, and each food is single ingestion.
Sponsors
Toyo Sugar Refining Co., Ltd.
Medical Corporation Seishinkai, Takara Clinic University of Miyazaki
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Japanese 2. Male or female 3. Subjects aged 20 or more 4. Healthy subjects
Exclusion criteria
Exclusion criteria: 1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage in daily use 5. Subjects currently taking medicines (include herbal medicines) and supplements 6. Subjects who are allergic to medications and/or the test-food-related products 7. Subjects who are pregnant, breast-feeding, and planning to become pregnant 8. Subjects who suffer from COVID-19 9. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 10. Subjects who are judged as ineligible to participate in the study by the physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The area under the curve of blood metabolites concentration | — |
Secondary
| Measure | Time frame |
|---|---|
| The maximum blood concentration of metabolites, the measured values at each assessment point* of blood metabolites concentration, and metabolites concentration in 24-hour urine collection *It indicates before test-food consumption, at one, two, four, six, and 24 hours after test-food consumption | — |
Countries
Japan
Contacts
Public ContactYushi Hashizume
Toyo Sugar Refining Co., Ltd. Research & Development Department
Outcome results
None listed